Verition Fund Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Verition Fund Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-80,800	Closed	-$819K	–	3063
2022 Q3	$819K	Buy	+80,800	New	+$816K	0.01%	1553

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Verition Fund Management's ARCK Position: Q4 2022 in Review

Verition Fund Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 80,800 shares — an estimated $819K sold.

Verition Fund Management first reported a position in ARCK in Q3 2022 and held it in 1 quarter. The position peaked at $819K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Verition Fund Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Verition Fund Management sold 80,800 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $819K.
Verition Fund Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q3 2022 and held it in 1 quarter.
Verition Fund Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $819K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.